Consequently, it was applied in the down-regulation of endogenous genes (BCL2 and GAPDH) of the human cancer cell, showing that TX-2 knocked down expression of the target genes much more effectively than WT-HHRz in both mRNA and protein level (Supplementary Figure S24). This evidence concerns the gene BCL2 and cancer.